Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
Rainier Hematology-Oncology, WA
2487
mi
from 02139
Puyallup, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
Rainier Hematology-Oncology, WA
2487
mi
from 02139
Puyallup, WA
Click here to add this to my saved trials
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/17/2017
NWMS Tacoma — Medical Oncology & Infectious Diseases
2493
mi
from 02139
Tacoma, WA
Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo
A Pilot Study Evaluating the Effect of 'R' (Electro-Kinetically Altered Beverage) on Insomnia, Fatigue and Depression in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/17/2017
NWMS Tacoma — Medical Oncology & Infectious Diseases
2493
mi
from 02139
Tacoma, WA
Click here to add this to my saved trials
Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
A Pilot Neoadjuvant Clinical Trial With Evaluation of Molecular Effects With Sorafenib Tosylate for Patients With Stage II or Greater Renal Cell Carcinoma
Status: Enrolling
Updated:  4/17/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
610
mi
from 02139
Chapel Hill, NC
Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
A Pilot Neoadjuvant Clinical Trial With Evaluation of Molecular Effects With Sorafenib Tosylate for Patients With Stage II or Greater Renal Cell Carcinoma
Status: Enrolling
Updated: 4/17/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
610
mi
from 02139
Chapel Hill, NC
Click here to add this to my saved trials
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Pilot Study of Cancer Resistance in Humans
Status: Enrolling
Updated:  4/17/2017
Wake Forest University Comprehensive Cancer Center
654
mi
from 02139
Winston-Salem, NC
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Pilot Study of Cancer Resistance in Humans
Status: Enrolling
Updated: 4/17/2017
Wake Forest University Comprehensive Cancer Center
654
mi
from 02139
Winston-Salem, NC
Click here to add this to my saved trials
Study of Patient Navigation to Promote Colon Cancer Screening
Randomized Controlled Trial of Patient Navigation to Increase Colorectal Cancer Screening Rates Among Community Health Center Patients
Status: Enrolling
Updated:  4/17/2017
Cambridge Health Alliance
0
mi
from 02139
Cambridge, MA
Study of Patient Navigation to Promote Colon Cancer Screening
Randomized Controlled Trial of Patient Navigation to Increase Colorectal Cancer Screening Rates Among Community Health Center Patients
Status: Enrolling
Updated: 4/17/2017
Cambridge Health Alliance
0
mi
from 02139
Cambridge, MA
Click here to add this to my saved trials
Herbal Therapy for Treatment of Recurrent Prostate Cancer
A Phase II Trial of a Combination Herbal Therapy for Men With Biochemical Recurrence of Prostate Cancer After Initial Local Therapy
Status: Enrolling
Updated:  4/18/2017
U.S.C./Norris Comprehensive Cancer Center
2586
mi
from 02139
Los Angeles, CA
Herbal Therapy for Treatment of Recurrent Prostate Cancer
A Phase II Trial of a Combination Herbal Therapy for Men With Biochemical Recurrence of Prostate Cancer After Initial Local Therapy
Status: Enrolling
Updated: 4/18/2017
U.S.C./Norris Comprehensive Cancer Center
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Lynn Cancer Institute
1218
mi
from 02139
Boca Raton, FL
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Lynn Cancer Institute
1218
mi
from 02139
Boca Raton, FL
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Lynchburg Hematology-Oncology Clinic
547
mi
from 02139
Lynchburg, VA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Lynchburg Hematology-Oncology Clinic
547
mi
from 02139
Lynchburg, VA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Ironwood Cancer and Research Centers
2286
mi
from 02139
Chandler, AZ
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Ironwood Cancer and Research Centers
2286
mi
from 02139
Chandler, AZ
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Moores UCSD Cancer Center
2574
mi
from 02139
La Jolla, CA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Moores UCSD Cancer Center
2574
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
John B. Amos Cancer Center
1018
mi
from 02139
Columbus, GA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
John B. Amos Cancer Center
1018
mi
from 02139
Columbus, GA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
The Cancer Center at DeKalb Medical
929
mi
from 02139
Decatur, GA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
The Cancer Center at DeKalb Medical
929
mi
from 02139
Decatur, GA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Northeast Georgia Medical Center
884
mi
from 02139
Gainesville, GA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Northeast Georgia Medical Center
884
mi
from 02139
Gainesville, GA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
900
mi
from 02139
Savannah, GA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
900
mi
from 02139
Savannah, GA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Joliet Oncology-Hematology Associates, Ltd.
874
mi
from 02139
Joliet, IL
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Joliet Oncology-Hematology Associates, Ltd.
874
mi
from 02139
Joliet, IL
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Beth Israel Deaconess Medical Center
2
mi
from 02139
Boston, MA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Beth Israel Deaconess Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Dartmouth Hitchcock Medical Center
105
mi
from 02139
Lebanon, NH
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Dartmouth Hitchcock Medical Center
105
mi
from 02139
Lebanon, NH
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Arena Oncology Associates PC
173
mi
from 02139
Lake Success, NY
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Arena Oncology Associates PC
173
mi
from 02139
Lake Success, NY
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Leo W. Jenkins Cancer Center - East Carolina University
576
mi
from 02139
Greenville, NC
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Leo W. Jenkins Cancer Center - East Carolina University
576
mi
from 02139
Greenville, NC
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
St. Luke's Cancer Center
252
mi
from 02139
Bethlehem, PA
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
St. Luke's Cancer Center
252
mi
from 02139
Bethlehem, PA
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Vasicek Cancer Center at Scott & White Memorial Hospital
1640
mi
from 02139
Temple, TX
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Vasicek Cancer Center at Scott & White Memorial Hospital
1640
mi
from 02139
Temple, TX
Click here to add this to my saved trials
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/18/2017
Municipal Institution "Cherkasy Regional Oncology Dispensary" of Cherkasy Regional Council
mi
from 02139
Cherkasy,
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/18/2017
Municipal Institution "Cherkasy Regional Oncology Dispensary" of Cherkasy Regional Council
mi
from 02139
Cherkasy,
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Ironwood Cancer and Research Center
2286
mi
from 02139
Chandler, AZ
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Ironwood Cancer and Research Center
2286
mi
from 02139
Chandler, AZ
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
South Bay Hematology Oncology
2680
mi
from 02139
Campbell, CA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
South Bay Hematology Oncology
2680
mi
from 02139
Campbell, CA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Medical Oncology Care Associates
2578
mi
from 02139
Orange, CA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Medical Oncology Care Associates
2578
mi
from 02139
Orange, CA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
American Institute of Research
2579
mi
from 02139
Whittier, CA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
American Institute of Research
2579
mi
from 02139
Whittier, CA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Florida Cancer Specialists
1247
mi
from 02139
Fort Myers, FL
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Florida Cancer Specialists
1247
mi
from 02139
Fort Myers, FL
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Georgia Cancer Specialists
923
mi
from 02139
Atlanta, GA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Georgia Cancer Specialists
923
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Northwest Georgia Oncology Centers, PC
932
mi
from 02139
Marietta, GA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Northwest Georgia Oncology Centers, PC
932
mi
from 02139
Marietta, GA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Rush University Medical Center
849
mi
from 02139
Chicago, IL
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Rush University Medical Center
849
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Jewish Hospital
821
mi
from 02139
Louisville, KY
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Jewish Hospital
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Nebraska Hematology-Oncology, PC
1319
mi
from 02139
Lincoln, NE
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Nebraska Hematology-Oncology, PC
1319
mi
from 02139
Lincoln, NE
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Hanover Medical Specialists
672
mi
from 02139
Wilmington, NC
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Hanover Medical Specialists
672
mi
from 02139
Wilmington, NC
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
The Christ Hospital Cancer Center Research
735
mi
from 02139
Cincinnati, OH
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
The Christ Hospital Cancer Center Research
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Dayton Clinical Oncology Program
704
mi
from 02139
Dayton, OH
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Dayton Clinical Oncology Program
704
mi
from 02139
Dayton, OH
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
South Carolina Oncology Associates, PA
789
mi
from 02139
Columbia, SC
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
South Carolina Oncology Associates, PA
789
mi
from 02139
Columbia, SC
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Coastal Bend Cancer Center
1787
mi
from 02139
Corpus Christi, TX
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Coastal Bend Cancer Center
1787
mi
from 02139
Corpus Christi, TX
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
The Center for Hematology-Oncology/Boca Raton Community Hospital, Inc
1217
mi
from 02139
Boca Raton, FL
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
The Center for Hematology-Oncology/Boca Raton Community Hospital, Inc
1217
mi
from 02139
Boca Raton, FL
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Cedar Valley Med Specialists
1081
mi
from 02139
Waterloo, IA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Cedar Valley Med Specialists
1081
mi
from 02139
Waterloo, IA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Frederick Memorial Hospital Regional Cancer Therapy Center
385
mi
from 02139
Frederick, MD
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Frederick Memorial Hospital Regional Cancer Therapy Center
385
mi
from 02139
Frederick, MD
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Oncology Hematology Care
725
mi
from 02139
Cincinnati, OH
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Oncology Hematology Care
725
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Pennsylvania State Hershey Cancer Institute
321
mi
from 02139
Hershey, PA
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Pennsylvania State Hershey Cancer Institute
321
mi
from 02139
Hershey, PA
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Sarah Cannon Research Institute
940
mi
from 02139
Nashville, TN
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Sarah Cannon Research Institute
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Mary Crowley Cancer Research Centers
1545
mi
from 02139
Dallas, TX
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Mary Crowley Cancer Research Centers
1545
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
University of Texas Southwestern Medical Center
1546
mi
from 02139
Dallas, TX
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
University of Texas Southwestern Medical Center
1546
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
University of Utah Hospitals and Clinics, Huntsman Cancer Institute
2088
mi
from 02139
Salt Lake City, UT
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
University of Utah Hospitals and Clinics, Huntsman Cancer Institute
2088
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
JSC A.Gvamichava National Oncology Center
mi
from 02139
Tbilisi,
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Bavituximab Plus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
JSC A.Gvamichava National Oncology Center
mi
from 02139
Tbilisi,
Click here to add this to my saved trials
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Ironwood Cancer and Research Center
2286
mi
from 02139
Chandler, AZ
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Ironwood Cancer and Research Center
2286
mi
from 02139
Chandler, AZ
Click here to add this to my saved trials
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
Baptist Clinical Research
1138
mi
from 02139
Jonesboro, AR
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
Baptist Clinical Research
1138
mi
from 02139
Jonesboro, AR
Click here to add this to my saved trials
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated:  4/18/2017
American Institute of Research
2579
mi
from 02139
Whittier, CA
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Status: Enrolling
Updated: 4/18/2017
American Institute of Research
2579
mi
from 02139
Whittier, CA
Click here to add this to my saved trials